Indian pharma companies to expand revenues by 9 to 11% in FY25 - Greater Kashmir
This will be driven by 9-11 percent revenue growth from the US market, 7-9 percent each from the European and domestic markets, and 11-13 percent from the emerging markets, according to credit rating ICRA
1 Oct 01:25 · Greater Kashmir